Lipid peroxidation and glutathione levels in porcine kidney PK15 cells after individual and combined treatment with fumonisin B1, beauvericin and ochratoxin A

Basic and Clinical Pharmacology and Toxicology

Volumn 100, Issue 3, 2007, Pages 157-164

  Klarić, Maja Šegvić ^a   Pepeljnjak, Stjepan ^a   Domijan, Ana Marija ^b   Petrik, József ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BEAUVERICIN; FUMONISIN B1; GLUTATHIONE; OCHRATOXIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; KIDNEY EPITHELIUM; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; CARCINOGENS; CELL SURVIVAL; CELLS, CULTURED; DEPSIPEPTIDES; DRUG INTERACTIONS; ENZYME INHIBITORS; EPITHELIAL CELLS; FUMONISINS; GLUTATHIONE; KIDNEY; LIPID PEROXIDATION; OCHRATOXINS; SWINE;

ANIMALIA; SUS;

EID: 33847036665     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.00019.x     Document Type: Article

References (44)

1. Harrison LR, Colvin BM, Green JT, Newman LE, Cole JR. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 1990;2:217-21.
2. Kellerman TS, Marasas WFO, Thiel G, Gelderblom WCA, Cawood M, Coetzer JAW. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J Vet Res 1990;57:269-75.
3. Ueno Y, Iijima K, Wang S-D et al. Fumonisins as a possible contributory risk factor for primary liver cancer: a 3-year study of corn harvested in Haimen, China, by HPLC and ELISA. Food Chem Toxicol 1997;35:1143-50.
4. Gelderblom WCA, Abel S, Smuts CM et al. Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion. Environ Health Perspect 2001;109:291-300.
5. Pepeljnjak S, Petrinec Z, Kovačić S, Šegvić M. Screening toxicity study in young carp (Cyprinus carpio L.) on feed amended with fumonisin B1. Mycopathologia 2002;156:139-45.
6. Riley RT, Wang E, Schroeder JJ et al. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat Toxins 1996;4:3-15.
7. Abado-Becognee K, Mobio TA, Ennamany R et al. Cytotoxicity of fumonisin B1: implication of lipid peroxidation and inhibition of protein DNA syntheses. Arch Toxicol 1998;72:233-6.
8. Abel S, Gelderblom WCA. Oxidative damage and fumonisin B1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology 1998;131:121-31.
9. Rumora L, Kovačić S, Rozgaj R, Čepelak I, Pepeljnjak S, Žanić-Grubišić T. Cytotoxic and genotoxic effects of fumonisin B1 in rabbit kidney RK13 cell line. Arch Toxicol 2002;76:55-61.
10. Hamill RK, Higgens CE, Boaz HE, Gorman M. The structure of beauvericin: a new depsipeptide antibiotic toxic to Artemia salina. Tetrahedron Lett 1969;49:4255-8.
11. Grove JF, Pople M. The insecticidal activity of beauvericin and the enniatin complex. Mycopathologia 1980;70:103-5.
12. Ojcius DM, Zychlinsky A, Zheng LM, Young JD. Ionophoreinduced apoptosis: a role of DNA fragmentation and calcium fluxes. Exp Cell Res 1991;197:43-9.
13. Castlebury LA, Sutherland JB, Tanner LA, Henderson AL, Cerniglia CE. Use of a bioassay to evaluate the toxicity of beauvericin to bacteria. World J Microbiol Biotechnol 1999;15:119-21.
14. Dombrink-Kurtzman MA. Fumonisin and beauvericin induce apoptosis in turkey peripheral blood lymphocytes. Mycopathologia 2003;156:357-64.
15. Tomoda H, Huang XH, Cao J et al. Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics. J Antibiot 1992;45:1626-32.
16. Kouri K, Lemmens M, Lemmens-Gruber R. Beauvericin-induced channels in ventricular myocytes and liposomes. Biochim Biophys Acta 2003;1609:203- 10.
17. Creppy EE, Roschenthaler R, Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem Toxicol 1984;22:883-6.
18. Krogh P. Causal association of mycotoxic nephropathy. Med Mycol Zbl Bakt 1980;8:291-9.
19. Thuvander A, Funseth E, Breitholtz-Emanuelsson A, Hallen IP, Oskarsson A. Effects of ochratoxin A on the rat immune system after perinatal exposure. Nat Toxins 1996;4:141-7.
20. Pfohl-Leszkowicz A, Pinelli E, Bartsch H, Mohr U, Castegnaro M. Seks- and strain-specific experssion of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol Carcinog 1998;23:76-85.
21. Radić B, Fuchs R, Peraica M, Lucić A. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Lett 1997;91:105-9.
22. Peraica M, Domijan A-M, Fuchs R, Lucic A, Radić B. The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 1999;110:105-12.
23. Peraica M, Domijan A-M, Matašin M et al. Variations of ochratoxin A concentration in the blood of healthy populations in some Croatian cities. Arch Toxicol 2001;75:410-4.
24. Domijan A-M, Peraica M, Jurjević Ž, Ivić D, Cvjetković B. Fumonisin B1, fumonisin B2, zearalenone and ochratoxin A contamination of maize in Croatia. Food Addit Contam 2005;22:677-80.
25. Jurjević Ž, Solfrizzo M, Cvjetković B, Avantaggiato G, Visconti A. Ochratoxin A and fumonisins (B1 and B2) in maize from Balkan nephropathy endemic and non endemic areas of Croatia. Mycotoxin Res 1999;15:67-80.
26. Jurjević Ž, Solfrizzo M, Cvjetković B, De Girolamo A, Visconti A. Occurrence of beauvericin in corn from Croatia. Food Technol Biotechnol 2002;40:91-4.
27. Zepnik H, Völkel W, Dekant W. Toxicokinetics of the mycotoxin ochratoxin A in F344 rats after oral administration. Toxicol Appl Pharmacol 2003;192:36-44.
28. IPCS (International Programme on Chemical Safety). Safety evaluation of certain mycotoxins in food. WHO Food Addit Ser 2001;47:103-415.
29. Petrik J, Žanić-Grubišić T, Barišić K et al. Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch Toxicol 2003;77:685-93.
30. Paciolla C, Dipierro N, Mule G, Logrieco A, Dipierro S. The mycotoxins beauvericin and T-2 induce cell death and alteration to the ascorbate metabolism in tomato protoplasts. Physiol Mol Plant Pathol 2004;65:49-56.
31. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
32. Weber F, Freudinger R, Schwerdt G, Gekle M. A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substances. Toxicol In Vitro 2005;19:135-43.
33. Yike I, Allan T, Sorenson WG, Deraborn DG. Highly sensitive protein translation assay for trichothecene toxicity in airborne particulates: comparison with cytotoxicity assays. Appl Environ Microbiol 1999;65:88- 94.
34. Barišić K, Petrik J, Rumora L, Čepelak I, Žanić-Grubišić T. Expression of Hsp70 in kidney cells exposed to ochratoxin A. Arch Toxicol 2002;76:218-26.
35. Norred WP, Wang E, Yoo H, Riley RT, Merrill AH. In vitro toxicology of fumonisins and the mechanistic implications. Mycopathologia 1992;117:73-8.
36. Abbas HK, Gelderblom WCA, Cawood ME, Shier WT. Biological activities of fumonisins, mycotoxins from Fusarium moniliforme in jimsonweed (Datura stramonium L.) and mammalian cell cultures. Toxicon 1993;31:345-53.
37. Schaaf GJ, Nijmeijer SM, Maas RFM, Roestenberg P, Groene EM, Fink-Gremmels J. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim Biophys Acta 2002;1588:149- 58.
38. Creppy EE, Chirappa P, Baudrimont I, Borracci P, Moukha S, Carratu MR. Synergistic effects of fumonisn B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity? Toxicology 2004;201:115-23.
39. Jow GM, Chou CJ, Chen BF, Tsai JH. Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium. Cancer Lett 2004;216:165-73.
40. Lin HI, Lee YJ, Chen BF et al. Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Cancer Lett 2005;230:248-59.
41. Kang YJ, Alexander JM. Alterations of the glutathione redox cycle status in fumonisin B1-treated pig kidney cells. J Biochem Toxicol 1996;11:121- 6.
42. Stockmann-Juvala H, Mikkola J, Naarala J, Loikkanen J, Elovaara E, Savolainen K. Oxidative stress induced by fumonisin B1 in continuous human and rodent neural cell cultures. Free Radic Res 2004;38:933-42.
43. Kubena LF, Edrington TS, Harvey RB, Philips TD, Sarr AB, Rottinghous GE. Individual and combined effects of fumonisin B1 present in Fusarium moniliforme culture and diacetoxyscirpenol or ochratoxin A in turkey poults. Poult Sci 1997;76:256-64.
44. Thuvander A, Wikman C, Gadhasson I. In vitro exposure of human lymphocytes to trichothecenes: individual variation in sensitivity and effects of combined exposure on lymphocyte function. Food Chem Toxicol 1999;37:639-48.